Faculty of Medicine and Health, Discipline of Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia.
Australian Paediatric Surveillance Unit, Kids Research Institute, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.
J Paediatr Child Health. 2022 Apr;58(4):611-617. doi: 10.1111/jpc.15784. Epub 2021 Oct 27.
We aimed to describe health-related out-of-pocket (OOP) expenses incurred by Australian families living with children with chronic and complex diseases.
A prospective pilot study of OOP expenses in families with children with tuberous sclerosis (TS) or mitochondrial disorders (MD) in 2016-2017. An initial survey assessed the family's financial situation, child's health functioning and estimated previous 6 months' and lifetime OOP expenses. Thereafter, families completed a survey each month for 6 months, prospectively tracking OOP expenses.
Initial surveys were completed by 13 families with 15 children; median age 7 years (range: 1-12); 5 with MD, 10 with TS. All families reported OOP expenses: 38% paid $2000 per annum, more than double the annual per-capita OOP costs reported for Australia by the Organisation for Economic Co-operation and Development. Eight families estimated $5000-$25 000 in OOP expenses over their child's lifetime and 62% of mothers reduced or stopped work due to caring responsibilities. Eleven families paid annual private health insurance premiums of $2000-$5122, but 72% said this was poor value-for-money. Prospective tracking by eight families (9 children) identified the median OOP expenditure was $863 (range $55-$1398) per family for 6 months. OOP spending was associated with visits to allied health professionals, non-prescription medicines, special foods, supplements and disposable items. Eight families paid for 91 prescription medications over 6 months.
All families caring for children with TS or MD reported OOP expenses. A larger study is needed to explore the affordability of health care for children living with a broader range of chronic diseases.
本研究旨在描述澳大利亚患有慢性和复杂疾病儿童的家庭的健康相关自付费用。
2016-2017 年对患有结节性硬化症(TS)或线粒体疾病(MD)的儿童的家庭进行前瞻性试点研究。初始调查评估了家庭的财务状况、儿童的健康功能以及估计前 6 个月和终生的自付费用。此后,家庭每月完成一项调查,为期 6 个月,前瞻性地跟踪自付费用。
共有 13 个家庭的 15 名儿童完成了初始调查;中位年龄为 7 岁(范围:1-12 岁);5 例为 MD,10 例为 TS。所有家庭均报告有自付费用:38%的家庭每年支付 2000 澳元,是经合组织报告的澳大利亚人均年度自付费用的两倍多。8 个家庭估计他们的孩子一生中有 5000-25000 澳元的自付费用,62%的母亲因照顾责任而减少或停止工作。11 个家庭支付每年 2000-5122 澳元的私人医疗保险费,但 72%的人认为这是物非所值。8 个家庭(9 名儿童)进行了前瞻性跟踪,发现这 6 个月每个家庭的自付支出中位数为 863 澳元(范围 55-1398 澳元)。自付支出与看理疗健康专业人员、非处方药物、特殊食品、补充剂和一次性用品有关。8 个家庭在 6 个月内支付了 91 种处方药。
所有照顾患有 TS 或 MD 儿童的家庭都报告有自付费用。需要进行更大规模的研究来探讨更广泛的慢性疾病患儿的医疗保健的可负担性。